Amitriptyline for Sleep: A Common Off-Label Habit With Thin Proof

You can’t sleep, and a doctor suggests a small dose of amitriptyline at bedtime. It’s been around for decades, and it isn’t a classic sleeping pill. Maybe it helps, or maybe you wake up groggy and wonder whether it’s doing anything at all. Both reactions make sense once you know what the drug is and how little it’s been studied for sleep.

Your brain uses histamine as one of its wake-up signals, and blocking it makes you drowsy. Amitriptyline is a tricyclic antidepressant, and a pharmacology review of tricyclics describes histamine H1 blockade as the most potent property these drugs share, which explains their sedation. Using a drug that touches this many receptors takes precision about dose, timing, and who’s taking it.

The standard first step for chronic insomnia is a behavioral treatment. The 2023 European guideline on insomnia recommends cognitive behavioral therapy for insomnia, or CBT-I, as the first-line treatment for adults of any age, delivered in person or digitally, and gives that recommendation its highest grade. The results are real, and the science is well established.

But CBT-I isn’t easy to access everywhere, and at Siggy we think that if you’re offered a nightly pill instead, you deserve a clear picture of the evidence behind it first.

Low-dose amitriptyline is one of the most common off-label answers to insomnia. This guide covers why it’s prescribed, what the first placebo-controlled trial found, where sleep guidelines stand, and which side effects matter even at small doses. The question is whether the drug’s benefit for sleep outweighs its risks for you, and that rests on the evidence.

What This Page Covers

• Why Is Amitriptyline Prescribed for Sleep?
• What Does the Research Show?
• What Do Sleep Guidelines Say?
• What Side Effects Matter at Low Doses?
• Who Should Be Most Cautious?
• How Do You Stop Taking It?
• What Else Can Help You Sleep?
• How Siggy Fits In
• Start Your Anonymous Intake

Why Is Amitriptyline Prescribed for Sleep?

Amitriptyline is approved for one thing: depression. The amitriptyline prescribing information lists relief of depressive symptoms as its only indication and starts adult outpatients at 75 mg a day. Insomnia isn’t on the label, so using it for sleep is off-label, which means a prescriber is using an approved drug for a purpose the FDA hasn’t reviewed.

Sleep doses are much smaller, usually 10 to 20 mg at bedtime. The label itself notes that a sedative effect may appear before any antidepressant effect, and that sedation is what people taking it for sleep are after. The DREAMING researchers note that licensed sleeping pills are generally recommended for less than 4 weeks, so low-dose amitriptyline is often chosen when someone needs help sleeping for several months.

The catch is that a drug can make you sleepy without being proven to treat insomnia. Drowsiness after a dose and better sleep over weeks are different outcomes, and only the second one counts as treatment.

What Does the Research Show?

For years, the honest answer was that nobody knew. A 2018 Cochrane review of antidepressants for insomnia found 23 randomized trials with 2,806 participants and no studies of amitriptyline at all, despite its common use. Low-dose doxepin, a related tricyclic, showed a modest improvement in sleep quality over placebo.

The first placebo-controlled answer came in 2025. In the DREAMING trial, Dutch general practices randomly assigned adults with trouble staying asleep to amitriptyline 10 to 20 mg, low-dose mirtazapine, or placebo for 16 weeks. At 6 weeks, amitriptyline lowered insomnia severity scores by 3.4 points more than placebo on a 28-point scale, which the researchers judged statistically significant but not clinically relevant. From 12 weeks on, there was no significant difference. Mirtazapine did better at 6 weeks, with a clinically relevant effect, but it also faded by 12 weeks.

The trial has limits. It enrolled 80 people, fewer than planned, largely because of COVID-19 restrictions. The authors noted that, given how small the amitriptyline effect was, more participants would likely not have made it clinically meaningful.

Real-world reports look more encouraging, but they can’t separate drug from expectation. In a sleep clinic survey of 752 patients taking 10 to 20 mg, 73.9% said their ability to stay asleep improved, while 66.1% reported at least one side effect. Without a placebo group, some of that improvement may reflect time, attention, or the natural ups and downs of insomnia.

What Do Sleep Guidelines Say?

The 2017 AASM guideline from the American Academy of Sleep Medicine made recommendations about 14 drugs, and amitriptyline wasn’t one of them. It suggested low-dose doxepin for trouble staying asleep and suggested against trazodone, both as weak recommendations. The European guideline lists low-dose sedating antidepressants as an option for short-term use of up to about 4 weeks when CBT-I isn’t enough, with longer use considered case by case.

Here’s how amitriptyline compares with other off-label and related options, based on those guidelines and trials:

Medication	FDA Approved for Insomnia	AASM 2017 Stance	Placebo-Controlled Evidence
Amitriptyline, 10 to 20 mg	No	No recommendation	One trial, small and short-lived
Doxepin, 3 to 6 mg	Yes, staying asleep	Suggested (weak)	Modest benefit in trials
Trazodone	No	Suggested against (weak)	Small benefit, low-quality evidence
Mirtazapine, 7.5 to 15 mg	No	No recommendation	One trial, benefit at 6 weeks only

Doxepin stands out because the low-dose doxepin label carries an FDA indication for insomnia with difficulty staying asleep, based on trials of up to 3 months. If a tricyclic is on the table for sleep, that’s the one with the most direct evidence. Our guides to trazodone for sleep and mirtazapine for sleep cover those options in more detail.

What Side Effects Matter at Low Doses?

Amitriptyline doesn’t only block histamine. The label describes an atropine-like action, which means it blocks acetylcholine, a messenger that helps control saliva, digestion, bladder emptying, and focus. That’s where many of its side effects come from, and some can appear even at sleep doses:

• Dry mouth and constipation
• Blurred vision
• Next-day drowsiness or grogginess
• Dizziness when standing up
• Trouble urinating
• Weight change

Interactions matter too. The label warns that amitriptyline may enhance the effects of alcohol and other sedating drugs. It also notes that drugs blocking the liver enzyme CYP2D6, including many SSRIs, can raise tricyclic levels, sometimes sharply, so tell your prescriber about every medication you take. At high doses, tricyclics can cause heart rhythm problems. For a fuller list, see our guide to amitriptyline side effects.

Who Should Be Most Cautious?

Older adults face the most risk. The amitriptyline label says people in this age group are particularly sensitive to its anticholinergic effects, including confusion, sedation, delirium, constipation, and urinary retention, and may be at increased risk for falls. It advises starting low and watching closely.

Long-term exposure is another consideration. In a large case-control study of 284,343 people 55 or older, the highest cumulative use of anticholinergic antidepressants was linked to 29% higher odds of dementia. That study measured total exposure over years and can’t prove cause, but it’s a reason to avoid open-ended use without a regular review.

The label also says amitriptyline shouldn’t be used during recovery from a recent heart attack or together with MAOI antidepressants, and it should be used carefully in people with glaucoma, urinary retention, or seizures.

How Do You Stop Taking It?

Don’t stop on your own after taking amitriptyline for a long stretch. The label notes that stopping abruptly after prolonged use can cause nausea, headache, and malaise. Even a gradual reduction can bring brief irritability, restlessness, and sleep disturbance within two weeks, which can feel like your insomnia coming back. A short, planned taper with your prescriber makes that easier to tell apart.

What Else Can Help You Sleep?

Insomnia is rarely just a medication question. CBT-I teaches you to rebuild the link between your bed and sleep, adjust your sleep window, and quiet the racing thoughts that keep you up. The European guideline recommends it first for adults with chronic insomnia, including those with other health conditions, and digital versions make it easier to reach.

Sleep problems also travel with anxiety and depression, and treating the underlying condition can help sleep along the way. If you’re lying awake with worry, our guide to anxiety and insomnia explains how the two feed each other, and our overview of depression and sleep covers the other direction.

Call 911 if someone may have taken too much amitriptyline, since tricyclic overdoses can be life-threatening. If you’re having thoughts of harming yourself, call 911 or call or text 988.

How Siggy Fits In

Siggy’s licensed prescribers diagnose and treat the full range of mental health conditions, including insomnia, anxiety, and depression. When sleep trouble is part of an anxiety or depression picture, treating that picture is often the more direct route. Siggy’s free, anonymous intake lets you describe your sleep, mood, and current medications, including any amitriptyline you already take. The intake gathers structured information and doesn’t diagnose you on its own, and a licensed prescriber reviews it before anything is prescribed.

Once you’re in care, you can check in with Siggy as your body adjusts and note side effects like grogginess as they come up, and your clinician determines the timing of follow-up care. Siggy isn’t an emergency service. This article is for education and isn’t a substitute for advice from your own prescriber. It reflects sources available as of November 2026.

Start Your Anonymous Intake

Low-dose amitriptyline is a common off-label sleep aid, but the best trial so far found only a small, short-lived benefit, and guidelines point to behavioral treatment first. If your sleep problems come with anxiety or low mood and you want a licensed prescriber to look at the whole picture, start your anonymous intake with Siggy. It’s free, there’s no name or email required, and a licensed prescriber reviews your full picture before anything is prescribed. You’ll get a downloadable summary you can share with any clinician.